O157 cell pellet and lysate fractions from Experiment I (LB, dRF, fRF) were concentrated using spin filters (MW cutoff 5000 Daltons), and digested with trypsin prior to tandem mass spectrometry (MS/MS) as described previously [17]. The enzymatically-digested samples were injected onto a capillary trap (LC Packings Acadesine ic50 PepMap) and desalted for 5 min with a flow rate of 3 μl/min of 0.1% v/v acetic acid. The samples were loaded onto an LC Packing® C18 Pep Map nanoflow HPLC column. The elution gradient of the HPLC column started at 3% solvent B, 97% solvent A and finished at 60% solvent B, 40% solvent

A for 95 min selleck chemical for protein identification. Solvent A consisted of 0.1% v/v acetic acid, 3% v/v acetonitrile (ACN), and 96.9% v/v H2O. Solvent B consisted of 0.1% v/v acetic acid, 96.9% v/v ACN, and 3% v/v H2O. LC-MS/MS analysis was carried out on a hybrid quadrupole-TOF mass spectrometer (QSTAR

elite, Applied Biosystems, Framingham, MA). The focusing potential and ion spray voltage was set to 225 V and 2400 V, respectively. The information-dependent acquisition (IDA) mode of operation was employed GSK1210151A clinical trial in which a survey scan from m/z 400–1800 was acquired followed by collision-induced dissociation (CID) of the four most intense ions. Survey and MS/MS spectra for each IDA cycle were accumulated for 1 and 3 s, respectively. Tandem mass spectra were extracted by ABI Analyst version 2.0. All MS/MS samples were analyzed using Mascot (Matrix Science, London, UK; version 2.2.2). Mascot was set up to search NCBI with taxonomy Bacteria database assuming the digestion enzyme trypsin. Mascot was searched with a fragment ion mass tolerance of 0.50 Da and a parent ion tolerance of 0.50 Da. Iodoacetamide derivative of Cys, deamidation of Asn and Gln, oxidation of Met, were specified in Mascot as variable modifications. Scaffold (version Scaffold-03-3-2, Proteome

Software Inc., Portland, OR) was used to validate MS/MS based peptide and protein identifications. Peptide identifications were accepted if they could be established at greater than 95.0% probability as specified by the Peptide Phenylethanolamine N-methyltransferase Prophet algorithm [22]. Protein identifications were accepted if they could be established at greater than 99.0% probability and contained at least 2 identified unique peptides. Proteins with single peptide hits were included if they exhibited high confidence based on low false discovery rates [23]. Relative protein abundance was estimated using the normailized total spectral counts [24]. Protein probabilities were assigned using the Protein Prophet algorithm [25]. Proteins that contained similar peptides and could not be differentiated based on MS/MS analysis alone were grouped to satisfy the principles of parsimony.